Lars E Laugsand1, Linn B Strand2, Carl Platou3, Lars J Vatten2, Imre Janszky4. 1. Department of Public Health, Faculty of Medicine, Norwegian University of Science and Technology, NTNU, Trondheim N-7491, Norway lars.e.laugsand@ntnu.no. 2. Department of Public Health, Faculty of Medicine, Norwegian University of Science and Technology, NTNU, Trondheim N-7491, Norway. 3. Department of Public Health, Faculty of Medicine, Norwegian University of Science and Technology, NTNU, Trondheim N-7491, Norway HUNT Research Centre, Norwegian University of Technology and Science, Trondheim, Norway Medical Department, Nord-Trøndelag Health Trust, Levanger, Norway. 4. Department of Public Health, Faculty of Medicine, Norwegian University of Science and Technology, NTNU, Trondheim N-7491, Norway Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden.
Abstract
AIMS: Insomnia is highly prevalent among heart failure patients, but only a few small studies have investigated insomnia symptoms and risk of heart failure. We aimed to assess the prospective association between self-reported insomnia symptoms and the risk of incident heart failure in a large Norwegian cohort. METHODS AND RESULTS: Baseline data on insomnia symptoms, including difficulty initiating sleep, difficulty maintaining sleep and having non-restorative sleep, socio-demographic variables, and health status, including established cardiovascular risk factors, were collected from 54 279 men and women 20-89 years of age who participated in the Nord-Trøndelag Health study (HUNT) between 1995 and 1997 and were free from known heart failure at baseline. The cohort was followed for incident heart failure from baseline through 2008. We used Cox proportional hazard models to assess the association of baseline insomnia symptoms with the risk of heart failure. A total of 1412 cases of heart failure occurred during a mean follow-up of 11.3 years (SD = 2.9 years), either identified at hospitals or by the National Cause of Death Registry. There was a dose-dependent association between the number of insomnia symptoms and risk of heart failure. The multi-adjusted hazard ratios were 0.96 (0.57-1.61), 1.35 (0.72-2.50), and 4.53 (1.99-10.31) for people with one, two, and three insomnia symptoms, compared with people with none of the symptoms (P for trend 0.021). CONCLUSIONS: Insomnia is associated with an increased risk of incident heart failure. If our results are confirmed by others and causation is proved, evaluation of insomnia symptoms might have consequences for cardiovascular prevention. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Insomnia is highly prevalent among heart failurepatients, but only a few small studies have investigated insomnia symptoms and risk of heart failure. We aimed to assess the prospective association between self-reported insomnia symptoms and the risk of incident heart failure in a large Norwegian cohort. METHODS AND RESULTS: Baseline data on insomnia symptoms, including difficulty initiating sleep, difficulty maintaining sleep and having non-restorative sleep, socio-demographic variables, and health status, including established cardiovascular risk factors, were collected from 54 279 men and women 20-89 years of age who participated in the Nord-Trøndelag Health study (HUNT) between 1995 and 1997 and were free from known heart failure at baseline. The cohort was followed for incident heart failure from baseline through 2008. We used Cox proportional hazard models to assess the association of baseline insomnia symptoms with the risk of heart failure. A total of 1412 cases of heart failure occurred during a mean follow-up of 11.3 years (SD = 2.9 years), either identified at hospitals or by the National Cause of Death Registry. There was a dose-dependent association between the number of insomnia symptoms and risk of heart failure. The multi-adjusted hazard ratios were 0.96 (0.57-1.61), 1.35 (0.72-2.50), and 4.53 (1.99-10.31) for people with one, two, and three insomnia symptoms, compared with people with none of the symptoms (P for trend 0.021). CONCLUSIONS:Insomnia is associated with an increased risk of incident heart failure. If our results are confirmed by others and causation is proved, evaluation of insomnia symptoms might have consequences for cardiovascular prevention. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Yishul Wei; Jennifer R Ramautar; Michele A Colombo; Diederick Stoffers; Germán Gómez-Herrero; Wisse P van der Meijden; Bart H W Te Lindert; Ysbrand D van der Werf; Eus J W Van Someren Journal: Sleep Date: 2016-12-01 Impact factor: 5.849
Authors: Nancy S Redeker; Andrea K Knies; Christopher Hollenbeak; H Klar Yaggi; John Cline; Laura Andrews; Daniel Jacoby; Anna Sullivan; Meghan O'Connell; Joanne Iennaco; Lisa Finoia; Sangchoon Jeon Journal: Contemp Clin Trials Date: 2017-01-31 Impact factor: 2.226
Authors: Nancy S Redeker; Sangchoon Jeon; Laura Andrews; John Cline; Daniel Jacoby; Vahid Mohsenin Journal: J Clin Sleep Med Date: 2015-10-15 Impact factor: 4.062
Authors: Henrik B Jacobsen; Silje E Reme; Grace Sembajwe; Karen Hopcia; Tore C Stiles; Glorian Sorensen; James H Porter; Miguel Marino; Orfeu M Buxton Journal: Am J Ind Med Date: 2014-05-08 Impact factor: 2.214